NDLI: In silico identification of potential drug targets in Clostridium difficile R20291: modeling and virtual screening analysis of a candidate enzyme MurG

Content Provider	Springer Nature Link
Author	Ezhilarasan, Vijayalakshmi Sharma, Om Prakash Pan, Archana
Copyright Year	2012
Abstract	Clostridium difficile is an etiologic agent of a variety of gastrointestinal diseases in human including mild sporadic diarrhea and severe life-threatening pseudomembranous colitis. The continuous rise of C. difficile infection worldwide accompanied by rapid emergence of multidrug-resistant and hypervirulent strains has necessitated the search for novel drug targets. The present study is aimed at identifying putative therapeutic targets in this pathogen by in silico approach which encompassed four steps, viz, similarity search between pathogen and host, essentiality study using the database of essential genes, metabolic functional association study using Kyoto Encyclopedia of Genes and Genomes database, and choke point analysis. The study identified 19 promising drug targets which are non-homologous to host proteins, potentially essential for the pathogen, choke point enzymes, and participate in four pathogen-specific pathways, namely peptidoglycan biosynthesis, phosphotransferase system, two component system, and d-alanine metabolism pathways. The peptidoglycan biosynthesis pathway is the highest donor to the list of candidate target proteins. Furthermore, a three-dimensional model of one of the identified potential targets, MurG from peptidoglycan biosynthesis pathway, was constructed by homology modeling. Subsequently, by means of a virtual screening approach, the study identified eight potential inhibitors from small molecules databases, which have better docking scores, varying from −7.9 to −10.3 kcal/mol, and stronger binding affinity with target compared to known inhibitors and natural substrate of MurG. The docking analysis revealed that the active site residue Gln298 plays a critical role in ligand–target interactions which was validated through in silico mutational study. Other active site residues like Arg168, Ser198, Arg202, Ser269, and His297 were also found to play a role in binding interactions. The identified compounds may facilitate the development of new drugs to combat C. difficile-associated diseases.
Starting Page	2692
Ending Page	2705
Page Count	14
File Format	PDF
ISSN	10542523
Journal	Medicinal Chemistry Research
Volume Number	22
Issue Number	6
e-ISSN	15548120
Language	English
Publisher	Springer-Verlag
Publisher Date	2012-10-10
Publisher Place	New York
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Clostridium difficile Drug target MurG Modeling Docking study Inhibitor Pharmacology/Toxicology Biochemistry Cell Biology
Content Type	Text
Resource Type	Article
Subject	Organic Chemistry Pharmacology, Toxicology and Pharmaceutics

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Screening of potent antibacterial agents targeting Clostridium difficile virulence factor toxin B: an in silico approach

Discovery of a novel histone deacetylase 8 inhibitor by virtual screening

Identification of novel natural compound inhibitors for human complement component 5a receptor by homology modeling and virtual screening

Structure modeling and hybrid virtual screening study of Alzheimer’s associated protease kallikrein 8 for the identification of novel inhibitors

An in silico approach for the identification of inhibitors against Acetylcholinesterase

Studies on ornithine decarboxylase of Leishmania donovani: structure modeling and inhibitor docking

Pharmacophore modeling and structure-based virtual screening for a novel “switch region” target of bacterial RNA polymerase

Pharmacophore modeling, virtual screening, and molecular docking studies for discovery of novel Carbonic anhydrase IX inhibitors

3D QSAR pharmacophore-based virtual screening and molecular docking studies for the discovery of potential PDK1 inhibitors

In silico identification of potential drug targets in Clostridium difficile R20291: modeling and virtual screening analysis of a candidate enzyme MurG

Similar Documents

Screening of potent antibacterial agents targeting Clostridium difficile virulence factor toxin B: an in silico approach

Discovery of a novel histone deacetylase 8 inhibitor by virtual screening

Identification of novel natural compound inhibitors for human complement component 5a receptor by homology modeling and virtual screening

Structure modeling and hybrid virtual screening study of Alzheimer’s associated protease kallikrein 8 for the identification of novel inhibitors

An in silico approach for the identification of inhibitors against Acetylcholinesterase

Studies on ornithine decarboxylase of Leishmania donovani: structure modeling and inhibitor docking

Pharmacophore modeling and structure-based virtual screening for a novel “switch region” target of bacterial RNA polymerase

Pharmacophore modeling, virtual screening, and molecular docking studies for discovery of novel Carbonic anhydrase IX inhibitors

3D QSAR pharmacophore-based virtual screening and molecular docking studies for the discovery of potential PDK1 inhibitors

In silico identification of potential drug targets in Clostridium difficile R20291: modeling and virtual screening analysis of a candidate enzyme MurG